UPDATE : Friday, September 20, 2019
Biopharmaceutical firms rank high in Kosdaq market cap
Biopharmaceutical firms are showing strong performance on South Korea’s tec...
by Nam Doo-hyun  |  2017-11-13 15:25
KIST to transfer immune-enhancing tech to EuBiologics
The Korea Institute of Science and Technology (KIST) said Monday it has sig...
by Constance Williams  |  2017-11-13 12:14
Samsung Bioepis gets sales license for Samfenet
Samsung Bioepis said Thursday it has received domestic sales approval for S...
by Lee Han-soo  |  2017-11-09 16:03
GemVax & KAEL place 1st in patent competition
GemVax & KAEL said Thursday it obtained first place in a competition for se...
by Marian Chu  |  2017-11-09 14:26
Medipost’s CellTree emerges as nation’s leading cord blood bank
Korean celebrity couples, such as Ko So-young and Jang Dong-gun, Ki Sung-yu...
by Marian Chu  |  2017-11-09 11:32
Toolgen registers ‘reporter gene’ patent for US genome editing
Toolgen툴젠 said Wednesday that it has registered a patent on “reporter genes...
by Constance Williams  |  2017-11-08 16:36
Medipost gets Chinese patent for next-generation stem cell technology
MediPost has developed a next-generation culture method that can improve th...
by Constance Williams  |  2017-11-08 15:12
World’s 1st gene therapy for osteoarthritis administered in Korea
Kolon Life Sciences said Wednesday it administered the first dose of its In...
by Marian Chu  |  2017-11-08 12:52
ViroMed, Reyon in legal battle over gene therapy patent rights
The exclusive contract between ViroMed and Reyon Pharmaceutical to jointly ...
by Nam Doo-hyun  |  2017-11-07 14:10
TissueGene shares trade low in Kosdaq debut
TissueGene, a U.S.-based biopharmaceutical affiliate of the Kolon Group, sa...
by So Jae-hyeon  |  2017-11-06 15:47
Celltrion, Baxter BioPharma signs CMO accord for biosimilar production
Celltrion announced Friday that it has entered into a contract manufacturin...
by Constance Williams  |  2017-11-03 11:44
Samsung BioLogics, Merck to extend strategic alliance
Samsung BioLogics said Thursday that it has signed a memorandum of understa...
by Lee Han-soo  |  2017-11-02 11:20
Celltrion’s US sales of Remsima up 48% in Q3
Celltrion’s Remsima (ingredient: infliximab), a therapy to treat autoimmune...
by Nam Doo-hyun  |  2017-11-01 15:51
Myongji, Macrogen agree on genome information-based disease management
Macrogen said Monday that it has signed a business agreement with Myongji M...
by Lee Han-soo  |  2017-10-31 17:06
Celltrion unveils trial result for monoclonal antibody biosimilar
Celltrion said Tuesday that it has presented the results of phase 3 clinica...
by Lee Han-soo  |  2017-10-31 16:27
Myongji Hospital chairman becomes MGmed’s largest shareholder
Lee Wang-jun, chairman of Myongji Hospital’s board of directors and chairma...
by Lee Hye-seon  |  2017-10-31 13:26
Seoul, KHIDI opens ‘BioHub’ as control tower for bio-growth
The Seoul Metropolitan Government and the Korea Health Industry Development...
by Marian Chu  |  2017-10-30 16:35
‘Government’s undue intervention hinders growth of CROs’
The government’s excessive intervention in the biopharmaceutical service ma...
by Nam Doo-hyun  |  2017-10-27 17:35
Hugel Pharma launches 1st HA filler penis enlargement device
Hugel Biopharmaceuticals has obtained domestic sales license for the “Chaeu...
by Constance Williams  |  2017-10-27 17:29
CTCBIO inks deal to export to Middle East, North Africa
Korean biotech company CTCBIO said Friday it had sealed a deal with two org...
by Marian Chu  |  2017-10-27 17:11
Back to Top